Cross-cultural studies of neurodegenerative disorders are especially important when the disease in question is difficult to diagnose, particularly if symptoms of the illness include behavioral disturbances that may be interpreted differently in different cultures. One such disease is frontotemporal lobar degeneration (FTLD), an early-age-of-onset dementia that disproportionately affects social behavior. We report the demographic and neuropsychologic characteristics of more than 300 patients diagnosed with FTLD in the United States, Greece, and Turkey. We find that patients with the frontal variant of frontotemporal dementia (FTD) are diagnosed at an earlier age and report earlier symptom onset in the United States than in Greece or Turkey. Furthermore, neuropsychologic measures indicate that at diagnosis, FTD patients in the United States are less impaired than patients in Greece and Turkey. Patients with FTD in Greece and Turkey are diagnosed later in the disease, presumably because their behavioral symptoms are not easily detected by the medical system in these countries. Our study underscores the need to create culturally appropriate indices of the behavioral symptoms of FTLD, so that patients may be diagnosed and treated at an earlier stage.
F rontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disease affecting the frontal and anterior temporal lobes. Once considered rare, recent work suggests that FTLD is a common cause for dementia, particularly in patients under the age of 70 years. FTLD's prevalence is similar to that of Alzheimer disease with 15 cases per 100,000 between 45 and 64 years. 1, 2 Other studies suggest that FTLD accounts for up to 20% of all patients with degenerative dementias. 3, 4 FTLD is often further subdivided into 3 subtypes on the basis of differences in regional atrophy and symptom patterns. These 3 subtypes are (1) progressive nonfluent aphasia, in which patients primarily show deficits in verbal expression, and predominantly left-frontal atrophy; (2) frontal variant of frontotemporal dementia (FTD), in which first symptoms are generally behavioral disturbances and atrophy is symmetrical and predominately frontal; and (3) semantic dementia (SD) or temporal-variant frontotemporal dementia, in which patients gradually lose access to semantic concepts (ie, meanings of words) resulting from temporal atrophy.
To date, the bulk of the studies on the prevalence and demographic characteristics of FTLD have been limited to patient cohorts in the United States and the United Kingdom. 1, 2 Here, we present demographic characteristics of over 300 patients with FTLD seen in research clinics in the United States, Greece, and Turkey. In addition, patients presenting with progressive supranuclear palsy (PSP), a related disorder, are described because PSP and some FTLD patients show similar clinical and pathologic findings (t inclusions). These 2 patient groups are distinguishable, however, when behavioral symptoms dominate the early clinical presentation, as is the case in FTD. 5 Cross-cultural examination of FTLD is particularly important as this dementia is characterized by behavioral changes, and the interpretation and detection of such changes is likely to vary with culture. Therefore, by describing characteristics of FTLD in different cultures, investigators may gain insight into the core features of the disease and aid physicians across borders to identify and treat patients appropriately.
METHODS

Patients
We assessed patients in clinics in California, Greece, and Turkey. Comprehensive historical, neuropsychologic, neurologic, and neuroimaging data were collected in a standardized fashion at memory clinics in San Francisco, CA; Athens, Greece (2 clinics); and Izmir, Turkey. At the Memory and Aging Clinic in San Francisco, patients were recruited through an extensive referral process including tertiary centers across California. Patients were seen independently of their financial resources. The Turkish University Dementia Clinic is also a tertiary healthcare center. Patients were referred by either a neurologist from secondary healthcare center or from internal medicine physicians or primary care physicians working in the private or public medical systems. In Greece, patients were recruited via 2 different clinics, both part of the public medical system: patients could come to the General Hospital in Athens without referral, whereas patients seen through the University Hospital (Eginition) were almost exclusively referred through their neurologist, psychiatrist, or general practitioner. The directors of these clinics all have expertize and a special interest in FTLD and PSP and their clinics serve as specialized referral sites. In addition, the same criteria were used for diagnosis across the clinics, and the directors of both the Greek and Turkish clinics have spent time working and training at the Memory and Aging Clinic in San Francisco. They continue to collaborate with the San Francisco clinic and attend international conferences related to the diagnosis of FTLD.
Demographic characteristics included the age of disease onset, education, sex, and age at diagnosis. To assess whether the relative numbers of patients with FTLD subtypes and PSP differed between countries, we used a w 2 test.
Diagnostic Criteria
Patients were diagnosed with FTLD using the 1998 consensus criteria. 6 PSP diagnosis was based on the Litvan criteria. 7
Neuropsychologic Measures
The mini-mental status examination (MMSE) was administered to all patients in the language of the country in which they were tested. In addition, patients in the United States and Greece were also assessed using the Neuropsychiatric Inventory (NPI) 8 and the Clinical Dementia Rating Scale (CDR). 9 For the NPI, the total score and the caregiver distress scores were analyzed separately.
Data Analysis: Demographic Information
We performed 3 (country) Â 4 [diagnosis: FTD, SD, progressive non-fluent aphasia (PA), and PSP] analysis of variances (ANOVAs) on 3 dependent measures: age at diagnosis, age at disease onset, and education, with Tukey Honestly Significantly Differences (HSD) tests to further investigate significant effects. We also wondered whether sex differences between diagnoses would be similar between countries. Therefore, we first collapsed across countries to see if the diagnoses had different proportions of men and women. Then, we performed w 2 analyses for each country to see if the effect was observed.
Data Analysis: Neuropsychologic Measures
We performed another 3 (country) Â 4 (diagnosis) ANOVA on initial MMSE scores, with Tukey HSD post-hoc tests to further investigate the significant effects. For patients from Greece and the United States, we performed a similar ANOVA on total NPI scores and caregiver distress and CDR scores.
RESULTS
Patients
We assessed 336 patients across 3 clinics. Table 1 shows the distribution of patients by country and diagnosis. All 3 countries had more patients with FTD than with SD or PA. In Greece, a greater proportion of the patients studied were diagnosed with FTD than in the United States and in Turkey [w 2 (2) = 9.50, P<0.01]. In Turkey, no patients with SD were diagnosed during the course of this study.
Demographic Characteristics Age at Diagnosis
The ANOVA revealed a main effect of country [F(2, 365) = 3.48, P<0.05], a trend toward an effect of diagnosis [F(3, 365) = 79.01, P<0.08], and an interaction between country and diagnosis [F(5, 365) = 2.28, P<0.05]. These results are shown in Figure 1 . Whereas the age at diagnosis was not different in Greece or Turkey for different disorders or FTLD subtypes, in the United States, patients diagnosed with FTD were significantly younger than patients with PSP and SD (Tukey HSD, P<0.001 for both).
Age at Disease Onset
The ANOVA showed a main effect of country [F(2, 345) = 5.47, P<0.01] and a significant interaction [F(5, 354) = 2.35, P<0.05]. These results are shown in Figure 2 .
Overall, patients in Greece reported a higher age of onset than those in the United States (Tukey HSD, P<0.001). As well, only in the United States were patients with FTD reported to have symptoms earlier than patients with PSP or SD. From these results, we suspected that there may be a difference in the amount of time that passes between the onset of symptoms and diagnosis in the different countries. Therefore, we performed an ANOVA on the difference between age at onset and age at diagnosis. We did find a significant main effect of country [F(2, 353) = 35.21, P>001]. In the United States, the time United States  80  47  13  33  173  Greece  72  24  16  7  119  Turkey  16  0  8  20  44  Total  168  71  37  60  336 fvFTD indicates frontal-variant frontotemporal dementia; PSP, progressive supranuclear palsy; SD, semantic dementia. between diagnosis and the report of first symptoms was greater than in either Greece or Turkey (Tukey HSD, P<0.05). These results are seen in Table 2 .
Education
An ANOVA revealed a main effect of country on education [F(2, 343) = 39.54, P<0.001] with all countries significantly different from each other (Tukey HSD, P<0.001). Results are shown in Table 3 .
Sex
First, we collapsed across countries to see if men or women were more likely to show each of the disorders. Via binomial tests, we found that FTD and PSP patients were more likely than chance to be males than females. To investigate whether this distribution varied by country, we performed w 2 analyses for each disorder. Here, we found no differences between the countries [w 2 (2)<3.5, P>1]. The higher prevalence of men with FTD is in line with findings from other international studies. 10 
Neuropsychologic Measures
As there was a difference in education between countries, we included education as a covariate in our analyses of neuropsychologic measures.
Initial MMSE Score at Diagnosis
Our ANOVA showed a main effect of country [F(2,336) = 11.69, P<0.001], a main effect of diagnosis [F(3, 336) = 17.74, P<0.001] and a significant interaction of diagnosis and country [F(5, 336) = 3.72, P<0.001]. Post-hoc tests showed that in the United States, only the SD and PSP patients differed in their MMSE scores (P<0.05). In Greece, FTD patients showed higher MMSE scores than PA patients (P<0.05). PSP patients also showed higher MMSE scores than both SD and PA patients (P<0.05). In Turkey, PSP patients showed higher MMSE scores than both FTD and PA patients (P<0.05) and FTD patients also showed higher MMSE scores than PA patients (P<0.05). These results are shown in Figure 3 .
CDR and NPI Measures
To ensure sufficiently large group sizes, we restricted our ANOVA to patients with FTLD. We did not have NPI scores from patients in Turkey. With education as a covariate, we found a significant main effect of diagnosis on both NPI scores [NPI total: F(2, 199) = 10.37, P<0.001; NPI caregiver distress: F(2, 172) = 4.30, P<0.02]. We also found a trend toward an effect of country on NPI total [NPI total: F(1, 199) = 3.5, P<0.06] and a significant effect of country on caregiver distress scores [F(1, 172) = 6.27, P<0.02]. Post-hoc tests showed that FTD patients showed higher total and caregiver distress scores than PA and SD patients [Tukey HSD, all P<0.05]. These results are shown in Figures. 4A and B .
With education as a covariate, our ANOVA of CDR scores indicated a main effect of country [F(1, 229) = 10.34, P<0.001] and a trend toward a significant interaction between country and diagnosis [F(1, 229) = 2.62, P<0.075]. Post-hoc tests showed that only in the United States, FTD patients showed higher CDR scores than both SD and PA patients [Tukey HSD, P<0.05]. Results are shown in Figure 5 .
DISCUSSION
Our cross-cultural comparison of patient characteristics has shown that patients diagnosed with FTD and the other FTLD subtypes are diagnosed at a younger age in the United States than in either Greece or Turkey. Only in the United States were patients with FTD younger than patients with other FTLD subtypes or PSP. Furthermore, Alzheimer Dis Assoc Disord Volume 23, Number 1, January-March 2009 Frontotemporal Lobar Degeneration even the reported age of onset of symptoms is higher in Greece and Turkey than in the United States, particularly for patients with FTD. These patients are much more likely to be diagnosed on the basis of behavioral symptoms that include social interactions, than are patients with PSP, PA, or SD, who, in turn, are more likely to present with language or motor disturbances. Interestingly, how-ever, the proportion of patients with each of the subtypes of FTLD and the tendency for more FTD and PSP patients to be male is equivalent in the United States and Greece. This observation suggests that the age difference is not simply owing to a lower rate of incidence of the disease or disproportionate numbers of one of the subtypes. When we compared the amount of time between the reported onset of symptoms and diagnosis, we found that patients in the United States were more likely to report symptoms well before diagnosis than patients in Greece and Turkey. Previous research shows that in FTD, the first symptoms are primarily behavioral in nature. 11 Therefore, one may interpret these findings as suggesting that the initial behavioral symptoms of FTD are ignored, or are more likely to be accepted as a normal part of life in Greece and Turkey. In fact, when we compared patients seen in the outpatient clinic with patients in the inpatient (University) clinic in Greece, we found that patients who were seen in the outpatient clinic, who were usually self-referred, were older than patients seen in the inpatient clinic, who were generally referred by a neurologist or psychiatrist. These results further suggest that FTLD symptoms are less likely to be considered a medical issue in the general population in Greece.
Support for this hypothesis is also found in the neuropsychologic measures that indicate that at the time of diagnosis, patients with FTLD in Greece and Turkey are more impaired than patients in the United States. Even though we included education as a covariate in the analysis, these differences were significant, refuting the possibility that education alone can account for the lower neuropsychologic scores in Greece and Turkey. Scores on the MMSE are lower, and scores on the CDR are significantly higher in Greece. Although the MMSE is known to be a fairly ineffective test of cognitive deterioration in FTLD, it is a reasonable indicator of general cognitive function and among the most reliable neuropsychologic measures across cultures. These effects are particularly striking in the FTD subtype, in which the detection of behavioral symptoms that impair social interactions is most important.
The effect that behavioral symptoms have on caregiver distress, however, is significant in both the United States and Greece: caregivers whose loved ones are afflicted with FTD report feeling more distress than those who care for patients with PA or SD. Given these findings, it seems that earlier detection of FTD may be critical in improving the outcome and reducing caregiver distress in FTD patients who live in Greece and Turkey.
This report highlights important similarities with regard to key features of FTD across 3 different countries and cultures. In particular, FTD is highly prevalent in clinics in the United States, Turkey, and Greece with expertize in this condition. Also, the male predominance for FTD seen in previous studies is confirmed in the United States, Greece, and Turkey. Similarly, stress in caregivers who take care of patients with FTD is high inall 3 countries. These similarities are encouraging with regard to future epidemiologic research into FTD and related disorders. In Greece and Turkey, caregivers seem to be more likely to care for FTD within the family structure before seeking medical help. As better therapies emerge for FTD and related disorders, new strategies will be needed to educate the lay public and physicians regarding the medical implications of late-life behavioral syndromes in all 3 countries. 
